ISPC | iSpecimen Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.41 - 4.90
52 Week Range	3.41 - 15.80
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	509,333
Average Volume	86,002
Shares Outstanding	654,850
Market Cap	3,012,310
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2021-06-17

Valuation
Profitability
Growth
Health
P/E Ratio	-0.22
Forward P/E Ratio	N/A
EPS	-21.20
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	53
Country	USA
Website	ISPC

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

ISPC's peers: APDN, GTH, OLK, FONR, CSTL, XGN, OCX, PSNL, IDXG, TRIB, HTGM, INBS, BIAFW, SQL, TTOO, BIOC

*Chart delayed

Analyzing fundamentals for ISPC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see ISPC Fundamentals page.

Watching at ISPC technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ISPC Technicals page.